抗心律失常药物致严重心律失常一例
摘要
1临床资料
患者,女,62岁,退休公务员。因心悸1月,加重2天入院。患者一月前无诱因出现心悸,心电图诊断为室性早搏。服用“美托洛尔”每日12.5毫克,后加用“美西律”0.1,每日3次,症状没有明显改善。
出处
《包头医学》
2013年第4期248-248,共1页
Journal of Baotou Medicine
二级参考文献45
-
1王景峰,朱纯石,梅伯英.心律平和胺碘酮对心脏起搏阈值和强度—脉宽曲线的影响[J].中山医科大学学报,1994,15(2):138-141. 被引量:6
-
2张楠,郭继鸿.抗心律失常药物对心脏起搏阈值的影响[J].中华心律失常学杂志,2006,10(5):389-391. 被引量:9
-
3[1]CIBIS- Ⅱ Investigators and Committees. The cardiac insufficiency bisoprolol study Ⅱ (CIBIS- Ⅱ ) a randomised trial[ J ].Lancet, 1999,353:9.
-
4[2]Hjalmarson F, Goldstein S. Effects of controlled - release metoprolol on total mortality, hospitalization, and well - being in patients with heart failure:The metoprolol CR/XL randomized international trial in congestive heart failure( MERIT- HF)[ J].JAMA, 2000,283:1 295.
-
5[3]Packer M, Fowler M, Rouleau J, et al. COPERNICUS (carvedilol prosective randomized cumulative survival trial):a multicenter randomized double- blind, placebo - controlled study to determine the effect of carvedilol onmortality in severe congestive heart failure[J] . Cardiovasc Drugs Ther, 1999,13:24.
-
6[4]The International Steering Committee on Behalt of the MERIT - HF Study Group. Rationale, design and organization of metoprolol CR/XL randomized intervention trial heart failure ( MERIT - HF) [ J ]. Am J Cardiol, 1997,80( Suppl 9B): 54J.
-
7[5]MERIT- HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure( MERIT - HF) [ J]. Lancet,1999,353:2 001.
-
8[6]The CIBIS Ⅱ Scientific Committee. Design of the cardiac insufficiency bisoprolol study Ⅱ ( CIBIS Ⅱ ) [ J ]. Fundam Clin Pharmacol, 1997,1 1: 138.
-
9[7]Simon T, Mary - Krause M, Funck - Brentano C, et al. Female gender is an independent predictor of survival in patient with chronic heart failure:results from the cardiac insufficiency bisoprolol study(CIBIS Ⅱ ) [J]. Circulation, 1999, 100(Suppl 1 ):1.
-
10[8]Mc Gowan J, Murphy R, Cleland JGF. Carvedilol for heart failure:clinical trial in progress[J]. Heart failure Rev, 1999,4:89.
共引文献20
-
1洪晓丹,任斌,李卓敏,黎曙霞,唐蕾,吴昭怡.2002-2004年广东地区抗心律失常药用药分析[J].广东药学,2005,15(6):50-52.
-
2高芝萍,刘江.2003—2005年太原市中心医院抗高血压药应用分析[J].中国药物与临床,2007,7(8):628-630.
-
3廖德宁,杨志健.抗心律失常药物致心律失常作用的机制[J].内科理论与实践,2008,3(4):232-234. 被引量:7
-
4张华耀,黄树满,刘培良,袁龙.卡维地洛治疗慢性心力衰竭临床疗效观察[J].中国实用医药,2008,3(34):138-139. 被引量:1
-
5杨维明.预防因抗心律失常而致心律失常的发生[J].吉林医学,2009,30(10):932-932.
-
6谢立新,李桂娇,肖永祺.心脏永久起搏器术后阈值升高的防治[J].中西医结合心脑血管病杂志,2009,7(12):1456-1458. 被引量:2
-
7谢立新,肖永祺.心肌纤维化致起搏器晚期阈值升高2例[J].实用医学杂志,2009,25(24):4265-4265. 被引量:2
-
8何学明.抗心律失常药导致室性心律失常187例临床分析[J].检验医学与临床,2010,7(22):2462-2463. 被引量:4
-
9王琳,毛小平,何娜.页岩气开采技术[J].石油与天然气化工,2011,40(5):504-509. 被引量:38
-
10关敬树,徐涛,王昊,廖德宁.TRIaD指标与药物所致的尖端扭转性室性心动过速[J].中国心脏起搏与心电生理杂志,2012,26(2):98-100. 被引量:3
-
1顾平.血浆瘦素水平与中心性肥胖及代谢综合征关系的探讨[J].南京医科大学学报(自然科学版),2009,29(11):1619-1620. 被引量:8
-
2冯超,张卫东,王佑娟,赵丽惠,宋永莉,陈晓军.993例退休公务员超重肥胖现状及其与高血压的相关性分析[J].现代预防医学,2009,36(10):1883-1884. 被引量:2
-
3李娟,杨芳,杨月梅.抗生素口服致过敏性休克1例[J].临床合理用药杂志,2013,6(22):15-15.
-
4黄昌华,韦晓平,潘美珍,张林桂,麦慧冰,钟富玲,余绚霞.深圳市公务员心血管病主要危险因素调查[J].中国临床保健杂志,2004,7(2):89-91. 被引量:1
-
5孙新宇.读懂父母的“脆弱”[J].心理与健康,2013(10):12-13.
-
6张隆光,康琳,刘晓红.老年难治性便秘1例的诊治[J].中华老年多器官疾病杂志,2012,11(11):854-855.